Home / Resources / Preclinical resources

临床前

最新资源

A Tutorial on the Development of a Physiologically Inspired PKRO Model for Monoclonal Antibodies

A Tutorial on the Development of a Physiologically Inspired PKRO Model for Monoclonal Antibodies

First-in-human dosing model for MDX2004, a novel trispecific CD3xCD28/4-1BB antibody-fusion protein for advanced malignancies

First-in-human dosing model for MDX2004, a novel trispecific CD3xCD28/4-1BB antibody-fusion protein for advanced malignancies

Certara Announces New Release of Integral® Software

Certara Announces New Release of Integral® Software

精选资源

New Approach Methodologies (NAMs): By the numbers

New Approach Methodologies (NAMs): By the numbers

Fact Sheet, Guide

Upcoming preclinical webinars

网络研讨会

AI-Powered PK Reporting: From Days to Minutes

2026 年 1 月 15 日 – 10am to 10:45am ET

网络研讨会

Alternative parameters in NCA using Phoenix WinNonlin

2026 年 1 月 21 日 – 10:00 -10:45a,m ET

网络研讨会

Certara Simcyp 教育网络研讨会系列第 4 部分：餐后药物吸收的变化及基于建模方法的预测现实性[日语]

2026 年 1 月 29 日 – 10:00 am – 11:30 am, Japan time

Latest preclinical blogs

All Preclinical - Blog

药物开发中 PK/PD 建模的机器学习

美国 FDA MIDD 配对试点计划如何帮助赞助商

Gain Nonclinical Drug Safety Insights with Real-Time Data Analysis

揭秘临床 DDI 研究：精准测量代谢产物

细胞疗法开发的主要考虑因素

支持生物等效性和仿制药审批的 PBPK 建模

在以下活动中与我们的专家会面

JPM 2026 44th Annual Healthcare Conference & Biotech Showcase

January 12 - 16, 2026 – San Francisco, CA

ICoP 2026 India

January 28 - 31, 2026

MVA Oncology Network

2026 年 2 月 4 日

All preclinical resources

Alternative parameters in NCA using Phoenix WinNonlin

Certara Products - Phoenix, Modeling and Simulation - PK/PD, Webinar

MVA Oncology Network

Clinical Pharmacology, Model Informed Drug Development, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Conference

A Tutorial on the Development of a Physiologically Inspired PKRO Model for Monoclonal Antibodies

Modeling and Simulation - QSP, Publication

First-in-human dosing model for MDX2004, a novel trispecific CD3xCD28/4-1BB antibody-fusion protein for advanced malignancies

Certara Products - Certara IQ, Modeling and Simulation - QSP, Poster

From Unstructured Data to Dose Insights: Applying Modern AI to Exposure Bracketing

Certara Products, Certara.AI, Webinar

ICoP 2026 India

Certara Products - Simcyp, Certara Services, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - QSP, Conference

New Approach Methodologies (NAMs): By the numbers

Certara Services, Modeling and Simulation, New Approach Methodologies (NAMs), Fact Sheet, Guide

New Approach Methodologies: Redefining Animal Testing Alternatives

New Approach Methodologies (NAMs), Podcast, Press Coverage

On Virtual Twin® models in rare disease research, with Piet van der Graaf

Modeling and Simulation - QSP, Podcast, Press Coverage

AI-Powered PK Reporting: From Days to Minutes

Certara Products, Certara Products - Phoenix, Clinical Pharmacology, Webinar

History and Evolution of Innovations in Clinical Pharmacology

Clinical Pharmacology, Model Informed Drug Development, Modeling and Simulation, Publication

10 Strategic Foundations for Early Drug Development

Certara Services, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Guide

1
2
3
……
64
›

订阅时事通讯

为什么订阅？因为改变药物开发不仅是我们的目标，更是我们的执着追求。如果这也是您的想法，那么请第一时间了解新见解，与我们一起推动科学发展。

© 2026 Certara. 保留所有权力。 | 法律 | 隐私政策

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software